Codexis

Codexis Crescimento de EBIT

O Crescimento do EBIT Ano a Ano de Codexis (CDXS) em 30 de out. de 2026 é 28,67 %. No ano anterior, Crescimento do EBIT Ano a Ano foi 14,03 % — uma variação de 104,38% (superior).

Crescimento de EBIT

28,67 %

YoY

104,38%

Última atualização:

Crescimento do EBIT Ano a Ano de Codexis é 2025 28,67 % . Crescimento do EBIT Ano a Ano de Codexis era 2024 14,03 % . Ele decresce em 104,38% superior em comparação com o ano anterior.

A Codexis Crescimento de EBIT História

  • 3 anos

  • 10 anos

  • 25 anos

  • Max

Crescimento de EBIT
Data
Crescimento de EBIT
1 de jan. de 2018
50,83 USD
1 de jan. de 2019
-11,10 USD
1 de jan. de 2020
-90,61 USD
1 de jan. de 2021
5,11 USD
1 de jan. de 2022
-53,68 USD
1 de jan. de 2023
-95,15 USD
1 de jan. de 2024
14,03 USD
1 de jan. de 2025
28,67 USD
A Codexis Crescimento de EBIT História
ANOCrescimento de EBITYoY
28,67 %+104,38%
14,03 %-114,75%
-95,15 %+77,24%
-53,68 %-1.149,92%
5,11 %-105,64%
-90,61 %+716,17%
-11,10 %-121,84%
50,83 %-130,22%
-168,22 %+1.546,14%
-10,22 %-117,22%
59,34 %—

Aceda a estes dados via API Eulerpool

100.000 pedidos/mês grátis · sem cartão

Codexis Análise de ações

O que Codexis faz? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis é uma das empresas mais populares na Eulerpool.com.

Perguntas frequentes sobre ação Codexis

Crescimento do EBIT Ano a Ano de Codexis é 28,67 % em 2025.

Na Eulerpool você encontra o histórico completo do Codexis de Crescimento do EBIT Ano a Ano desde 2006, com valores anuais, gráficos e análises detalhadas.

O crescimento do EBIT mede a mudança percentual no lucro operacional. Mostra se as operações principais de uma empresa estão se tornando mais lucrativas.

Para avaliar de Crescimento do EBIT Ano a Ano, é essencial compará-lo com pares do mesmo setor e indústria. Na Eulerpool, você pode encontrar comparações diretas de setor para Crescimento do EBIT Ano a Ano.

de Crescimento do EBIT Ano a Ano é um fator-chave para investidores. Mudanças nesta métrica podem sinalizar fundamentos em melhoria ou deterioração, impactando diretamente o preço das ações. Na Eulerpool, você pode acompanhar Codexis de Crescimento do EBIT Ano a Ano historicamente e em tempo real.

Aceda a estes dados via API Eulerpool

100.000 pedidos/mês grátis · sem cartão

Crescimento — Codexis

Todas as Métricas Financeiras — Codexis